Latest Breaking News On - Cynata therapeutics limited - Page 1 : comparemela.com

Further CYP-001 GvHD Clinical Data Published in Nature Medicine

/PRNewswire/ Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics,.

Cynata Reports Breakthrough GvHD Treatment Results

Cynata Therapeutics Limited (AU:CYP) has released an update. Cynata Therapeutics Limited has reported promising two-year survival data for its CYP-.

Cynata Therapeutics Reports Options Expiry

Cynata Therapeutics Limited (AU:CYP) has released an update. Cynata Therapeutics Limited has announced the cessation of 300,000 options due to thei.

Cynata Therapeutics Unveils Investor Update

Cynata Therapeutics Limited (AU:CYP) has released an update. Cynata Therapeutics Limited, an Australian biotech firm focused on stem cell and regen.

Patient Enrolment Completed in CYP-006TK Diabetic Foot Ulcer Clinical Trial